Antiviral antireflection member and antiviral half-mirror member

The antiviral antireflection and half mirror members address visibility and antiviral concerns in face shields by using a multilayer structure with antiviral agents and antireflection properties, ensuring clear visibility and rapid virus neutralization.

JP2024163429APending Publication Date: 2024-11-22FUKUBI KAGAKU IND
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
JP2023079017
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-12
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Conventional face shields suffer from reduced visibility due to light reflection and lack antiviral properties, especially in environments where viruses tend to adhere.

Method used

An antiviral antireflection member and antiviral half mirror member are developed, comprising a multilayer structure with specific layers such as a visible light-transmitting base material, hollow silica particles, silane coupling agents, metal chelates, and antiviral agents, providing both antireflection and antiviral properties.

Benefits of technology

The members achieve high visibility with reduced light reflection and effective antiviral protection, quickly decomposing or rendering non-toxic attached viruses, thereby preventing their spread.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024163429000001_ABST
    Figure 2024163429000001_ABST
Patent Text Reader

Abstract

To provide an antiviral antireflection member and an antiviral half-mirror member having antiviral properties and antireflection properties.SOLUTION: An antiviral antireflection member comprises a visible light-transmitting base material, an antireflection layer having at least a low refractive index layer with a refractive index of 1.47 or less that is obtained by curing a composition containing hollow silica particles, a silane coupling agent, and a metal chelate, and a protective layer which is superimposed on one surface of the antireflection layer and has a thickness in the range of 10 nm or more and 50 nm or less that is obtained by curing a composition containing a silane coupling agent, a metal chelate, and an antiviral agent.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a visible light transmissive anti-viral antireflection member and an anti-viral half mirror member. [Background technology]

[0002] In recent years, with the spread of coronavirus infections such as COVID-19, face shields to prevent saliva containing the virus from scattering and adhering to the face are becoming more common, especially among medical personnel. These face shields generally consist of a transparent resin plate that covers the face and a band-like fastener that secures the resin plate to the head.

[0003] For example, Patent Document 1 discloses a face shield containing an inorganic antibacterial agent in the contact area that comes into contact with the face, and Patent Document 2 discloses an antibacterial face shield with an iodine-based antibacterial agent volatilization sheet attached to the front. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] Patent Publication No. 2022-062763 [Patent Document 2] Utility Model Registration No. 3233719 Summary of the Invention [Problem to be solved by the invention]

[0005] Many face shields have a transparent front panel that is curved to fit the face, raising concerns that visibility may be reduced due to light reflection, etc. In addition, face shields are used in environments where viruses and other contaminants are likely to adhere, so it is preferable for them to have antiviral properties.

[0006] However, conventional transparent resin materials used in face shields only have either antiviral properties or antireflective properties, and there has been a demand for a light-transmitting resin material that has both antiviral properties and antireflective properties and is suitable for face shields, partitions, and the like.

[0007] The present invention has been made in consideration of the above problems, and has an object to provide an anti-viral antireflection member and an anti-viral half mirror member that have anti-viral properties and antireflection properties. [Means for solving the problem]

[0008] The antiviral antireflective member of the present invention has the following configuration. (1) An antiviral antireflective member according to a first aspect of the present invention is characterized by comprising: a visible light transmissive substrate; an antireflective layer having at least a low refractive index layer having a refractive index of 1.47 or less and formed by curing a composition containing hollow silica particles, a silane coupling agent, and a metal chelate; and a protective layer disposed on one side of the antireflective layer, formed by curing a composition containing a silane coupling agent, a metal chelate, and an antiviral agent, and having a thickness in the range of 10 nm or more and 50 nm or less.

[0009] (2) The antiviral antireflective member according to a second aspect of the present invention is the antiviral antireflective member according to the first aspect, further comprising an antifouling layer containing a fluorine-based resin formed on one surface of the protective layer.

[0010] (3) An antiviral antireflection member according to a third aspect of the present invention is characterized in that in the first or second aspect, the composition of the antireflection layer further contains the antiviral agent.

[0011] (4) An antiviral antireflective member according to a fourth aspect of the present invention is any one of the first to third aspects, characterized in that the antiviral agent is an ion or a compound containing at least one metal selected from Ag, Cu, Zn, Pt, Au, and Ti.

[0012] (5) An antiviral antireflective member according to a fifth aspect of the present invention is any one of the first to third aspects, characterized in that the antiviral agent is dispersed in the protective layer as fine particles having an average particle size in the range of 20 nm or more and 50 nm or less.

[0013] The anti-viral half mirror member of the present invention has the following configuration. (6) The antiviral half mirror member according to a sixth aspect of the present invention is characterized by comprising: a visible light transmissive base material; a half mirror layer having at least a high refractive index layer having a refractive index of 1.60 or more, which is formed by curing a composition containing high refractive index inorganic particles, a silane coupling agent, and a metal chelate; and a protective layer arranged on one side of the half mirror layer, which is formed by curing a composition containing a silane coupling agent, a metal chelate, and an antiviral agent, and has a thickness in the range of 10 nm or more and 50 nm or less. Effect of the Invention

[0014] According to the present invention, it is possible to provide an antiviral antireflection member and an antiviral half mirror member having antiviral properties and antireflection properties. [Brief description of the drawings]

[0015] [Figure 1] FIG. 2 is an enlarged cross-sectional view showing a main part of an antiviral antireflective member according to one embodiment of the present invention. [Diagram 2] FIG. 2 is an enlarged cross-sectional view showing a main part of an anti-viral half mirror member according to one embodiment of the present invention. [Diagram 3] FIG. 1 is an external perspective view showing a face shield using an antiviral antireflective member according to one embodiment of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0016] Hereinafter, an antiviral antireflection member and an antiviral half mirror member according to one embodiment of the present invention will be described with reference to the drawings. Note that each embodiment shown below is specifically described to better understand the gist of the invention, and does not limit the present invention unless otherwise specified. In addition, the drawings used in the following description may show the main parts enlarged for convenience in order to make the features of the present invention easier to understand, and the dimensional ratios of each component may not necessarily be the same as the actual ones.

[0017] [Anti-viral anti-reflective material] FIG. 1 is an enlarged cross-sectional view of a main portion of an antiviral antireflection member according to one embodiment of the present invention. The antiviral antireflection member 10 is a visible light transmissive multilayer plate that can be suitably used as, for example, a face shield or a transparent partition plate. The antiviral antireflective member 10 of this embodiment is a laminate in which, from the bottom up, a resin substrate (substrate) 11, a hard coat layer 12, an antireflective layer 13, a protective layer 14, and an antifouling layer 15 are laminated in this order. When such an antiviral antireflective member 10 is used in an environment where external light is incident from one side, it is sufficient to use the antifouling layer 15 side as the light incident side (outer surface side).

[0018] (Visible light transmissive substrate) The visible light transmissive substrate in this embodiment is made of a resin substrate or a glass substrate. (Resin substrate) The resin substrate 11 of the present embodiment is a support substrate that supports each layer laminated on top of the upper layer, and is made of a visible light transmissive resin material, such as acrylic resin, polycarbonate resin, polyethylene terephthalate resin, polyallyl diglycol carbonate resin, polystyrene resin, AS resin, and silicone resin.

[0019] Of these, acrylic resin has high strength and higher visible light transmittance than inorganic glass, and is therefore suitable for the resin substrate 11. Polycarbonate resin has better impact resistance than acrylic resin, and is also excellent in heat resistance and cold resistance, and is therefore suitable for the resin substrate 11.

[0020] The thickness of the resin base material 11 may be, for example, in the range of 0.3 mm to 10 mm. If the thickness is less than 0.3 mm, there is a concern that the strength of the entire antiviral antireflection member 10 will be too low. If the thickness exceeds 10 mm, there is a concern that the weight of the entire antiviral antireflection member 10 will be too heavy and that processability will be deteriorated.

[0021] The glass substrate of the present embodiment is not particularly limited as long as it is glass having a composition that can be strengthened by chemical treatment, but glass containing alkali metal ions or alkaline earth metal ions with smaller ionic radius is preferable.

[0022] Specific examples of the glass substrate include soda-lime glass, alkali silicate glass, alkali aluminosilicate glass, aluminoborosilicate glass, borosilicate glass, etc., among which those containing sodium ions are preferred, and glass containing 5% by weight or more of sodium ions is most preferred. The thickness of such glass substrates is usually about 2 mm to 8 mm.

[0023] (Hard coat layer) The hard coat layer 12 is used when a resin substrate is used, and is a layer that prevents the resin substrate 11 from being damaged by external stress or the like and imparts chemical resistance to the resin substrate 11. The hard coat layer 12 of this embodiment is composed of a cured composition containing an acrylate resin, a metal chelate, a silane coupling agent, and solid silica particles.

[0024] The thickness of the hard coat layer 12 may be, for example, in the range of 1.0 μm to 10 μm. If the thickness is less than 1 μm, there is a concern that the strength characteristics relative to the resin substrate 11 will be too low. If the thickness exceeds 10 μm, there is a concern that the visible light transmittance will decrease.

[0025] The acrylate resin used in the hard coat layer 12 may be a mixture of an ultraviolet curable resin, such as urethane acrylate, epoxy acrylate, or polyester acrylate, and an acrylic resin, or may be either one of them.

[0026] An example of the urethane acrylate used in the hard coat layer 12 is a urethane acrylate having four or more functional groups. The urethane acrylate having four or more functional groups forms a hard portion by curing. Therefore, the resin substrate 11 having the hard coat layer 12 has high chemical resistance.

[0027] A urethane acrylate having four or more functionalities is a compound obtained by reacting a terminal isocyanate compound, which is a reaction product of a polyisocyanate compound and a polyol compound having multiple hydroxyl groups, with a hydroxyl group-containing (meth)acrylate (a reaction product of a terminal isocyanate compound and a hydroxyl group-containing (meth)acrylate), and has four or more (meth)acryloyl groups.

[0028] For example, a compound obtained by reacting pentaerythritol di(meth)acrylate with a terminal isocyanate compound to introduce two (meth)acryloyl groups at each of the two ends of the isocyanate compound is used as a tetrafunctional urethane acrylate. Also, a compound obtained by reacting pentaerythritol tri(meth)acrylate with a terminal isocyanate (e.g., trihexadiethylene diisocyanate) to introduce three (meth)acryloyl groups at each of the molecular chain ends is used as a hexafunctional urethane acrylate.

[0029] The urethane acrylate used in the hard coat layer 12 may be a trifunctional or lower functional urethane acrylate.

[0030] Examples of metal chelates used in the hard coat layer 12 include compounds of titanium, zirconium, aluminum, tin, niobium, tantalum, and lead that contain bidentate ligands. Note that a bidentate ligand is a chelating agent that has two coordination sites, that is, two atoms that can be coordinated to a metal, and generally forms a 5- to 7-membered ring with O, N, and S atoms to form a chelate compound. Examples of these bidentate ligands are acetylacetonate, ethylacetoacetate, diethylmalonate, dibenzoylmethanate, salicylate, glycolate, catecholate, salicylaldehyde, oxyacetophenonate, biphenolate, pyromeconate, oxynaphthoquinonate, oxyanthraquinonate, tropolonate, binokitylate, glycinato, alaninato, anthroninato, picolinate, aminophenonate, Examples of the naphthyl amine include benzoyl amine, ethanol amine, mercaptoethyl amine, 8-oxyquinolinate, salicylaldiminate, benzoin oximate, salicylaldoximate, oxyazobenzenato, phenylazonaphtholato, β-nitroso-α-naphtholato, diazoaminobenzenato, biuretato, diphenylcarbazonate, diphenylthiocarbazonate, biguanidato, and dimethylglyoximate.

[0031] The metal chelate compound is preferably a compound represented by the following general formula (1). M 1 (Li) k (X) m-k (1) In formula (1), M 1 is titanium, zirconium, aluminum, tin, niobium, tantalum or lead, Li is a bidentate ligand, X is a monovalent group, m is M 1 and k is the valence of M 1 is a number equal to or greater than 1, but not exceeding the valence of the atom.

[0032] M 1 As the metal, titanium, zirconium and aluminum are preferable. X is preferably a hydrolyzable group, and among these, an alkoxy group is particularly preferred.

[0033] Examples of the metal chelate compound represented by formula (1) include Ti chelate compounds, Zr chelate compounds, and Al chelate compounds.

[0034] The content of the metal chelate compound is preferably 0.1 to 3.0 parts by mass, and more preferably 0.5 to 1.5 parts by mass, relative to 100 parts by mass of the acrylate resin contained in the hard coat layer 12. When the content of the metal chelate compound is within the above range, the adhesion to the antireflection layer 13 as the upper layer can be improved.

[0035] The silane coupling agent used in the hard coat layer 12 is a component that enhances adhesion to the resin substrate 11 and the antireflection layer 13. It is also a component that prevents the solid silica particles from falling off and keeps them stably dispersed and supported. The silane coupling agent includes a compound represented by the following general formula (2). R 1 n -Si(OR 2 ) 4-n (2) In formula (2), R 1 is an alkyl or alkenyl group, R 2 is an alkyl group, an alkoxyalkyl group, an acyloxy group or a halogen atom, and n is the number 1 or 2.

[0036] R 1 Examples of the alkyl group include alkyl groups such as a methyl group, an ethyl group, and a propyl group, and alkenyl groups such as a vinyl group. The alkyl group may be substituted with a functional group such as a halogen atom such as chlorine, a mercapto group, an amino group, a (meth)acryloyl group, or an oxirane ring-containing group. R 2 is an alkyl group, an alkoxyalkyl group, an acyloxy group, or a halogen atom, and is bonded to a silicon atom. 2 is a hydrolyzable group.

[0037] Such a silane coupling agent undergoes hydrolysis and polycondensation at the same time to form a polymer connected in a network shape by Si-O-Si bonds. Therefore, the use of such a silane coupling agent can make the hard coat layer 12 denser. In the composition used to produce the hard coat layer 12, at least a part of the silane coupling agent is present as a hydrolyzate.

[0038] The content of the silane coupling agent is preferably 1 to 30 parts by mass, and more preferably 10 to 15 parts by mass, relative to 100 parts by mass of the acrylate resin contained in the hard coat layer 12. When the content of the silane coupling agent is 1 part by mass or more, the adhesion to the resin substrate 11 and the antireflection layer 13 can be improved. On the other hand, when the content of the silane coupling agent is 30 parts by mass or less, the external stress applied to the antireflection layer 13 can be sufficiently absorbed.

[0039] The solid silica particles used in the hard coat layer 12 have the effect of increasing the adhesion with the antireflection layer 13. A specific example of the solid silica particles that can be used is solid colloidal silica (solid silica sol). Here, "solid" refers to a particle having a density of 1.9 g / cm. 3 This means the above.

[0040] The solid silica particles preferably have an average particle size of 5 to 500 nm. If the average particle size of the solid silica particles is within the above range, properties such as hardness can be uniformly imparted to the entire hard coat layer 12. The refractive index of the solid silica particles is preferably, for example, 1.44 to 1.50. If the refractive index of the solid silica particles is within the above range, properties such as hardness can be uniformly imparted to the entire hard coat layer 12.

[0041] Such solid silica particles are commercially available in the form of a sol in which the solid silica particles are dispersed in an organic solvent such as isopropanol or methyl isobutyl ketone.

[0042] The content of the solid silica particles is preferably 80 parts by mass or less, more preferably 10 to 60 parts by mass, and even more preferably 20 to 50 parts by mass, relative to 100 parts by mass of the acrylate contained in the hard coat layer 12. When the content of the solid silica particles is within the above range, the adhesion of the hard coat layer 12 to the antireflection layer 13 can be improved.

[0043] (Anti-reflection layer) The antireflection layer 13 is a layer that imparts an antireflection function to the antiviral antireflection member 10. The antireflection layer 13 of this embodiment is composed of a cured composition containing a metal chelate, a silane coupling agent, and hollow silica particles.

[0044] The thickness of the antireflection layer 13 may be, for example, about 50 nm to 200 nm. The antireflection layer 13 has a refractive index of, for example, 1.47 or less, and includes a low refractive index layer as the outermost layer. Note that, although the antireflection layer 13 of the present embodiment has a single-layer structure and is composed of only a low refractive index layer, the antireflection layer 13 may be a laminate of two or more layers having different refractive indexes.

[0045] Specific examples of the metal chelate and silane coupling agent used in the antireflection layer 13 may be the same as those exemplified above in the description of the hard coat layer 12 .

[0046] Hollow colloidal silica (hollow silica sol) can be used as the hollow silica particles used in the antireflection layer 13. Here, "hollow" refers to a particle having a density of 1.5 g / cm 3 This means the following:

[0047] The hollow silica particles preferably have an average particle size in the range of 10 nm to 150 nm. When the average particle size of the hollow silica particles is within the above range, the visible light transmittance of the resin substrate 11 is not impaired, and a certain level of strength and hardness can be ensured, and properties such as scratch resistance can be imparted. The refractive index of the hollow silica particles is preferably less than 1.44. If the refractive index of the hollow silica particles is within the above range, the resin substrate 11 can have a certain level of strength and hardness without impairing its light transmittance, and can be provided with properties such as scratch resistance.

[0048] Hollow silica particles are produced, for example, by synthesizing silica in the presence of a surfactant that serves as a template, and then calcining the silica to decompose and remove the surfactant. They are commercially available in the form of a sol dispersed in an organic solvent such as isopropanol or methyl isobutyl ketone.

[0049] The hollow silica particles preferably have a content of 5 to 50 mass % relative to the total mass of the silane coupling agent and the metal chelate, the content of the silane coupling agent is preferably 15 to 94 mass %, and the content of the metal chelate is preferably 1 to 35 mass %.

[0050] It is also preferable that the antireflection layer 13 contains an antiviral agent (antibacterial agent). Compounds that have generally been confirmed to have antiviral effects include, for organic compounds, alcohols such as ethanol and isopropyl alcohol, phenolic compounds such as phenol, isopropylmethylphenol, and thymol, pyridine compounds such as zinc pyrithione and sodium pyrithione, chlorine compounds such as sodium hypochlorite, quaternary ammonium salt compounds such as alkylbenzylammonium chloride, didecyldimethylammonium chloride, and polyhexamethylene biguanide, and polyphenolic compounds such as epigallocatechin gallate and tannin. On the other hand, for inorganic compounds, metals and metal compounds, and photocatalytic oxides such as titanium oxide and zinc oxide are included.

[0051] Alcohol-based antiviral agents include ethanol and isopropyl alcohol. In particular, ethanol is widely used as disinfectant in medical and general merchandise products. These alcohol-based antiviral agents can inactivate enveloped viruses, such as influenza viruses and the novel coronavirus (COVID-19), by destroying the envelope (cell membrane) and denaturing the membrane proteins. On the other hand, they are ineffective against non-enveloped viruses, which do not have an envelope (cell membrane) and have a capsid located on the outermost surface.

[0052] Phenol-based antiviral agents include phenol (carbolic acid), 4-isopropyl-3-methylphenol (isopropylmethylphenol (IPMP), Biosol), and 2-isopropyl-5-methylphenol (thymol). Of these, isopropylmethylphenol (IPMP, Biosol) has a wide antibacterial activity (antibacterial spectrum) against bacteria, yeast, etc., and is highly safe, with low acute oral toxicity, so it is widely used as a disinfectant in pharmaceuticals and quasi-drugs, a preservative in cosmetics, etc.

[0053] Representative examples of pyridine-based antiviral agents include zinc pyrithione and sodium pyrithione, which have antibacterial and antifungal properties. Among these, zinc pyrithione is a zinc complex of a pyridine derivative, and is a broad-spectrum antiviral and antibacterial ingredient that is widely used in disinfectants for dandruff and itching in shampoos and cosmetics, as well as in antibacterial and deodorizing treatments for textiles, antifungal treatments, and antifungal agents in ship bottom paints and adhesives. Zinc pyrithione destroys protons (H + It is believed that they exert their antiviral and antibacterial properties by inhibiting membrane transport of the pump (electrochemical potential difference due to proton gradient), inhibiting the synthesis or activity of respiratory enzymes or lipase, a group of enzymes that hydrolyze the ester bonds that make up lipids.

[0054] An example of a chlorine-based antiviral agent is sodium hypochlorite. Sodium hypochlorite is alkaline and has oxidizing, bleaching, and bactericidal properties, so it is widely used in medical settings and food manufacturing facilities, as well as in drinking water and pool water, and as a disinfectant and bleach for areas around water. The antiviral properties of sodium hypochlorite include destruction of cell membranes, denaturation of proteins, and DNA damage due to its strong oxidizing power.

[0055] Cationic antiviral agents include polyhexamethylene biguanide and quaternary ammonium salt compounds. Examples include alkylbenzylammonium chloride (benzalkonium chloride) and dimethyldidecylammonium chloride. Benzalkonium chloride is listed in the Japanese Pharmacopoeia and the Standards for Quasi-Drug Raw Materials, and is widely used as a disinfectant for hands and skin as a pharmaceutical or quasi-drug. Meanwhile, dimethyldidecylammonium chloride (commonly known as DDAC) is used in wood preservation and antiviral processing for textiles. The antiviral action of cationic agents is expressed by causing cell membrane destruction and protein denaturation due to the effects of hydrophobic and hydrophilic interactions derived from cationic (positive charge) and molecular structure.

[0056] Polyphenol-based antiviral agents include complex aromatic compounds with many phenolic hydroxyl groups, such as epigallocatechin gallate, a catechin, and tannins found in plant leaves and fruits, as well as in the hands. The antiviral mechanism of these compounds is presumed to be due to their denaturation due to adsorption to proteins, as they contain many phenolic hydroxyl groups.

[0057] Metal-based antiviral agents include metal particles, compounds containing metals or metal ions, and the like, for example, ions or compounds containing at least one metal selected from Ag, Cu, Zn, Pt, and Au. Specific examples include inorganic carriers carrying Ag, Cu, etc., and nanoparticles of metal compounds such as copper iodide (CuI). These are used as antiviral agents in kitchen items such as food sheets, sanitary products, toiletries, preservatives for cosmetics, textile products, and the like. Metal-based antiviral agents, for example Ag, are basically in an ionized state (Ag + ) is believed to be active. Ag + Ions bind to cell membranes and membrane proteins, causing protein denaturation and functional inhibition. Furthermore, when taken up into cells, they inhibit respiratory enzymes, generating reactive oxygen species (free radicals, such as hydroxyl radicals), which promote the denaturation of proteins, etc., and are thought to exert an antiviral effect.

[0058] Metal oxides include titanium oxide (TiO2) and zinc oxide (ZnO). Titanium oxide (TiO2) crystal systems include rutile, anatase, and brookite types, with anatase in particular being used as an antiviral agent in textile products, kitchenware, toiletries, residential wall materials (tiles, interior walls, exterior walls), and window glass for transportation. The antiviral properties of metal oxides are as follows: In the case of titanium oxide (TiO2), photoexcitation causes electrons to be excited into the conduction band and holes to be excited into the valence band, respectively, resulting in charge separation. After this, the electrons react with oxygen to produce superoxide ions (O2 - ), and the positive holes react with water to generate hydroxyl radicals (·OH). It is believed that these radicals react with and decompose cell membranes, proteins, etc., thereby inactivating the virus.

[0059] In this embodiment, when the antireflection layer 13 contains an antiviral agent (antibacterial agent), the above-mentioned metal-based antiviral agent is used from the standpoint of durability and ease of addition to the mixture.

[0060] (protective layer) The protective layer 14 is a layer that protects the surface of the antiviral antireflection member 10 and also exhibits antiviral properties. When the antifouling layer 15 described below is not provided, this protective layer 14 becomes the outer surface side. The protective layer 14 of the present embodiment is composed of a metal chelate, a silane coupling agent, solid silica particles, and a hardened antiviral agent.

[0061] The thickness of the protective layer 14 may be, for example, about 10 nm to 50 nm. Specific examples of the metal chelate, silane coupling agent, and solid silica particles used in the protective layer 14 may be the same as the silane coupling agent and metal chelate exemplified above in the description of the hard coat layer 12. Specific examples of the antiviral agent may be the same as the antiviral agent exemplified above in the description of the antireflection layer 13. The antiviral agent of this embodiment uses ions or compounds containing at least one metal selected from Ag, Cu, Zn, Pt, Au, and Ti.

[0062] (Anti-stain layer) The antifouling layer 15 is provided as necessary. The antifouling layer 15 is a layer that exerts an antifouling effect on the outermost surface of the antiviral antireflection member 10. The antifouling layer 15 may be, for example, a cured mixture containing 50 to 550 parts by mass of an acrylic resin relative to 100 parts by mass of a fluororesin. By containing 50 parts by mass or more of an acrylic resin relative to 100 parts by mass of a fluororesin, the water repellency and oil repellency are enhanced, and the effect of suppressing adhesion of dirt derived from moisture and oil to the antiviral antireflection member 10 is obtained. In addition, by limiting the oil content ratio of the acrylic resin relative to 100 parts by mass of the fluororesin in the antifouling layer 15 to 550 parts by mass or less, it is possible to prevent the water repellency and oil repellency from decreasing and the antifouling property from deteriorating. If the content ratio of the acrylic resin in the antifouling layer 15 is too high, the water repellency and oil repellency at the outermost surface of the antiviral antireflection member 10 may decrease, resulting in a loss of antifouling property.

[0063] The fluororesin contained in the antifouling layer 15 is not particularly limited, but preferably contains at least one of polytetrafluoroethylene (PTFE), polychlorotrifluoroethylene (PCTFE), polyvinylidene fluoride (PVDF), and polyvinyl fluoride (PVF), for example. When the antifouling layer 15 contains any of the above fluororesins, the water repellency and oil repellency of the outermost surface of the antiviral antireflection member 10 as described above are further enhanced, and the effect of suppressing adhesion of dirt derived from moisture and oil to the surface is more significantly obtained.

[0064] The acrylic resin contained in the antifouling layer 15 is not particularly limited, but preferably contains at least one of polymethyl methacrylate resin, polymethyl acrylate resin, acrylic acid alkyl ester copolymer, and methacrylic acid alkyl ester copolymer, for example. When the antifouling layer 15 contains any of the above acrylic resins, the abrasion resistance of the outermost surface of the antiviral antireflection member 10 is further increased as described above, and the effect of suppressing abrasion on the surface is more significantly obtained.

[0065] As described above, the antiviral antireflective member 10 of the present embodiment contains an antiviral agent that has resistance to viruses such as coronaviruses typified by COVID-19 in at least the protective layer 14, and has an antireflective layer 13 composed of a low refractive index layer, etc., thereby making it possible to realize a visible light-transmitting transparent member that has both antiviral properties and antireflective effects.

[0066] By applying such antiviral antireflective material 10 to products that require visible light transparency and to which viruses may adhere, such as face shields and partitions in restaurants, it is possible to realize products in which even if viruses adhere, they are quickly decomposed and detoxified, and which have good visibility with little light reflection.

[0067] [Anti-viral half mirror material] FIG. 2 is an enlarged cross-sectional view of a main part showing an anti-viral half mirror member according to one embodiment of the present invention. The antiviral half mirror member 30 of this embodiment is a laminate in which, from the bottom up, a resin base material (substrate) 31, a hard coat layer 32, a half mirror layer 33, a protective layer 34, and an antifouling layer 35 are laminated in this order. When such an antiviral half mirror member 30 is used in an environment where external light is incident from one side, it is sufficient to use the antifouling layer 15 side so that it becomes the light incident side (outer surface side).

[0068] The resin base material (substrate) 31, protective layer 34, and antifouling layer 35 constituting the antiviral half mirror member 30 of this embodiment can each have the configurations shown in the embodiments of the antiviral antireflection member described above.

[0069] The half mirror layer 33 has at least a high refractive index layer having a refractive index of 1.60 or more, which is formed by curing a composition containing high refractive index inorganic particles, a silane coupling agent, and a metal chelate. As the high refractive index inorganic particles, for example, titanium oxide, zirconium oxide, niobium oxide, etc. can be used.

[0070] The silane coupling agent and metal chelate of the half mirror layer 33 may have the same configurations as those shown in the embodiments of the antiviral antireflection member described above.

[0071] According to the antiviral half mirror member 30 configured in this manner, at least the protective layer 34 contains an antiviral agent that has resistance to viruses such as coronaviruses typified by COVID-19, and the half mirror layer 33 is composed of a high refractive index layer or the like, thereby making it possible to realize a visible light transmissive transparent member that combines antiviral properties and a half mirror effect.

[0072] [Face shield] FIG. 3 is an external perspective view showing a face shield using an antiviral antireflective member according to one embodiment of the present invention. The face shield 20 of this embodiment has a face cover 21 constituted by the above-mentioned antiviral antireflective member 10, and a fixing part 22 that fixes this face cover 21 to the front part of the face of the human body.

[0073] According to the face shield 20 of this embodiment, even if the face cover 21 is curved, reflections and the like are reduced by the anti-reflection layer 13, and clear visibility can be obtained. In addition, since the protective layer 14 contains an antiviral agent, even if a virus adheres to the face cover 21 due to splashes of saliva, the virus is quickly decomposed or detoxified, so that further spread of the virus through the face shield 20 can be prevented.

[0074] Although the embodiments of the present invention have been described above, these embodiments are presented as examples and are not intended to limit the scope of the invention. These embodiments can be implemented in various other forms, and various omissions, substitutions, and modifications can be made without departing from the spirit of the invention. These embodiments and their modifications are included in the scope of the invention and its equivalents described in the claims, as well as in the scope and spirit of the invention. EXAMPLES

[0075] The effect of the present invention was verified. For the verification, an antiviral antireflection component was produced with the configuration shown in Figure 1. In producing the components, the film thickness of the protective layer and the amount of the antiviral agent added were changed to produce the following samples. (Example 1) The thickness of the protective layer was 20 nm, and the amount of the antiviral agent added was 10 mass %. (Example 2) The thickness of the protective layer was 20 nm, and the amount of the antiviral agent added was 20 mass %. (Example 3) The thickness of the protective layer was 20 nm, and the amount of the antiviral agent added was 30 mass %. (Example 4) The thickness of the protective layer was 10 nm, and the amount of the antiviral agent added was 20 mass %. (Example 5) The thickness of the protective layer was 50 nm, and the amount of the antiviral agent added was 20 mass %. (Comparative Example 1) The protective layer had a thickness of 20 nm and no antiviral agent was added. (Comparative Example 2) The thickness of the protective layer was 80 nm, and the amount of the antiviral agent added was 20 mass %.

[0076] The antiviral activity of each of the above samples was measured. The measurements were performed according to ISO 21702 (method for evaluating the antiviral effect of non-permeable surfaces). The evaluation was performed as follows: an antiviral activity value of 2.0 or more was ◯, a value less than 2.0 but exceeding 0 was △, and a value of 0 was ×. The reflectance and transmittance were also measured. The wavelength of light used in the measurements was 380 to 770 nm, and the measurements were performed using a spectrophotometer (V-650, manufactured by JASCO Corporation). The reflectance was the minimum value among the measured wavelengths, and the transmittance was the maximum value among the measured wavelengths. The results of these verifications are summarized in Table 1.

[0077] [Table 1]

[0078] According to the results shown in Table 1, in all of Examples 1 to 5 of the present invention, the reflectance was in the range of 0.6% to 2.5%, the transmittance was at least 97.2% or more, and antiviral activity was also ensured. On the other hand, there was no antiviral activity in the conventional Comparative Example 1, and the minimum bottom reflectance was 4.2% and the transmittance was only 95.5% in the Comparative Example 2. Therefore, the effect of the present invention was confirmed. [Explanation of symbols]

[0079] 10...Anti-viral anti-reflective material 11...Resin substrate 12...Hard coat layer 13...Anti-reflection layer 14...Protective layer 15...Anti-stain layer 20. Face shield 21. Face covering 22…Fixed part 30…Anti-virus half mirror material 33...Half mirror layer

Claims

1. A visible light transmissive substrate; an antireflection layer having at least a low refractive index layer having a refractive index of 1.47 or less, the low refractive index layer being formed by curing a composition containing hollow silica particles, a silane coupling agent, and a metal chelate; and a protective layer disposed on one side of the antireflection layer, the protective layer being formed by curing a composition containing a silane coupling agent, a metal chelate, and an antiviral agent, and having a thickness in the range of 10 nm or more and 50 nm or less.

2. 2. The anti-viral anti-reflective member according to claim 1, further comprising an antifouling layer containing a fluorine-based resin formed on one surface of the protective layer.

3. 3. The antiviral antireflective member according to claim 1, wherein the composition of the antireflective layer further contains the antiviral agent.

4. 3. The anti-viral antireflection member according to claim 1, wherein the anti-viral agent is an ion or a compound containing at least one metal selected from the group consisting of Ag, Cu, Zn, Pt, Au, and Ti.

5. 3. The anti-viral antireflection member according to claim 1, wherein the anti-viral agent is dispersed in the protective layer as fine particles having an average particle size in the range of 20 nm or more and 50 nm or less.

6. A visible light transmissive substrate; a half mirror layer having at least a high refractive index layer having a refractive index of 1.60 or more, the high refractive index layer being formed by curing a composition containing high refractive index inorganic particles, a silane coupling agent, and a metal chelate; and a protective layer disposed on one side of the half mirror layer, the protective layer being formed by curing a composition containing a silane coupling agent, a metal chelate, and an antiviral agent, and having a thickness in the range of 10 nm or more and 50 nm or less.

Citation Information

Patent Citations

  • Face shield

    JP2022062763A

  • Iodine-based antibacterial agent volatilization sheet for face shields, antibacterial face shields, and antibacterial face shield sets

    JP3233719U